Clinical Trial Update: Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares sequential entecavir followed by Pegasys versus Pegasys alone for HBeAg-positive chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis B, Chronic | Phase 4 | Status: UNKNOWN